Haematologica最新文献

筛选
英文 中文
ALK-positive histiocytosis and a clonally related chronic myelomonocytic leukemia. alk阳性组织细胞增多症和克隆相关的慢性髓细胞白血病。
IF 10.1 1区 医学
Haematologica Pub Date : 2025-09-11 DOI: 10.3324/haematol.2025.288275
Gerben E Breimer,Elisa A Rozeman,Weibel W Braunius,Laura G M Daenen,Lennart A Kester,Roos J Leguit,Rutger Mahieu,Nienke Solleveld-Westerink,Louise Straatman,Frans Schutgens
{"title":"ALK-positive histiocytosis and a clonally related chronic myelomonocytic leukemia.","authors":"Gerben E Breimer,Elisa A Rozeman,Weibel W Braunius,Laura G M Daenen,Lennart A Kester,Roos J Leguit,Rutger Mahieu,Nienke Solleveld-Westerink,Louise Straatman,Frans Schutgens","doi":"10.3324/haematol.2025.288275","DOIUrl":"https://doi.org/10.3324/haematol.2025.288275","url":null,"abstract":"Not available.","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":"70 1","pages":""},"PeriodicalIF":10.1,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145032067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of demographic factors on clinical outcomes of patients with acute myeloid leukemia. 人口统计学因素对急性髓系白血病患者临床结局的影响。
IF 10.1 1区 医学
Haematologica Pub Date : 2025-09-11 DOI: 10.3324/haematol.2025.288131
Cassandra Duarte,Diana Abbot,Grace Bosma,Andrew Kent,Marc Schwartz,Cailin Collins,Mathew G Angelos,Christine McMahon,Jonathon Gutman,Daniel A Pollyea,Maria Amaya
{"title":"Impact of demographic factors on clinical outcomes of patients with acute myeloid leukemia.","authors":"Cassandra Duarte,Diana Abbot,Grace Bosma,Andrew Kent,Marc Schwartz,Cailin Collins,Mathew G Angelos,Christine McMahon,Jonathon Gutman,Daniel A Pollyea,Maria Amaya","doi":"10.3324/haematol.2025.288131","DOIUrl":"https://doi.org/10.3324/haematol.2025.288131","url":null,"abstract":"Not available.","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":"129 1","pages":""},"PeriodicalIF":10.1,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145032145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CCRL2 and who? An important driver in TP53-mutant myeloid leukemias. CCRL2和谁?tp53突变型髓性白血病的重要驱动因素。
IF 10.1 1区 医学
Haematologica Pub Date : 2025-09-11 DOI: 10.3324/haematol.2025.288631
Olivia Arnold,Caner Saygin
{"title":"CCRL2 and who? An important driver in TP53-mutant myeloid leukemias.","authors":"Olivia Arnold,Caner Saygin","doi":"10.3324/haematol.2025.288631","DOIUrl":"https://doi.org/10.3324/haematol.2025.288631","url":null,"abstract":"Not available.","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":"33 1","pages":""},"PeriodicalIF":10.1,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145032066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Comment on: a case series of patients with β- thalassemia trait and iron overload: from multifactorial hepcidin suppression to treatment with mini-phlebotomies. β-地中海贫血特征和铁超载患者的病例系列:从多因子hepcidin抑制到小静脉切开术治疗。
IF 10.1 1区 医学
Haematologica Pub Date : 2025-09-11 DOI: 10.3324/haematol.2025.289073
Fabiana Busti,Domenico Girelli
{"title":"Response to Comment on: a case series of patients with β- thalassemia trait and iron overload: from multifactorial hepcidin suppression to treatment with mini-phlebotomies.","authors":"Fabiana Busti,Domenico Girelli","doi":"10.3324/haematol.2025.289073","DOIUrl":"https://doi.org/10.3324/haematol.2025.289073","url":null,"abstract":"Not available.","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":"24 1","pages":""},"PeriodicalIF":10.1,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145032065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The glutaminase activity of ASNS fuels glutamine metabolism in leukemia. ASNS的谷氨酰胺酶活性促进白血病的谷氨酰胺代谢。
IF 10.1 1区 医学
Haematologica Pub Date : 2025-09-11 DOI: 10.3324/haematol.2024.287099
Wai-Kin Chan,Lin Tan,Sara A Martinez,Di Du,Thomas D Horvath,Michael Pontikos,Leona A Rusling,Yulun Chiu,Bao Q Tran,Susan B Rempe,Sergei Sukharev,John N Weinstein,Philip L Lorenzi
{"title":"The glutaminase activity of ASNS fuels glutamine metabolism in leukemia.","authors":"Wai-Kin Chan,Lin Tan,Sara A Martinez,Di Du,Thomas D Horvath,Michael Pontikos,Leona A Rusling,Yulun Chiu,Bao Q Tran,Susan B Rempe,Sergei Sukharev,John N Weinstein,Philip L Lorenzi","doi":"10.3324/haematol.2024.287099","DOIUrl":"https://doi.org/10.3324/haematol.2024.287099","url":null,"abstract":"Not available.","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":"24 1","pages":""},"PeriodicalIF":10.1,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145032151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Comment on: Hepatitis B virus reactivation following T-cell engager therapy in multiple myeloma despite negative hepatitis B core antibody serology: implications for screening in patients with haematological malignancies. 对以下评论的回应:尽管乙型肝炎核心抗体血清学阴性,但多发性骨髓瘤患者在t细胞参与治疗后乙型肝炎病毒再激活:对血液系统恶性肿瘤患者筛查的意义
IF 7.9 1区 医学
Haematologica Pub Date : 2025-09-11 DOI: 10.3324/haematol.2025.289053
Matthew J Rees, Hang Quach, Darren Jardine, Alexander Thompson
{"title":"Response to Comment on: Hepatitis B virus reactivation following T-cell engager therapy in multiple myeloma despite negative hepatitis B core antibody serology: implications for screening in patients with haematological malignancies.","authors":"Matthew J Rees, Hang Quach, Darren Jardine, Alexander Thompson","doi":"10.3324/haematol.2025.289053","DOIUrl":"https://doi.org/10.3324/haematol.2025.289053","url":null,"abstract":"<p><p>Not available.</p>","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":" ","pages":""},"PeriodicalIF":7.9,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145033221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wild-type p53 overexpression in NPM1-mutated acute myeloid leukemia: potential implications for disease biology and therapy response. 野生型p53在npm1突变的急性髓性白血病中的过表达:对疾病生物学和治疗反应的潜在影响
IF 10.1 1区 医学
Haematologica Pub Date : 2025-09-11 DOI: 10.3324/haematol.2025.288054
Paul D Barone,Siarhei Dzedzik,Ashley S Kleinman,Christopher R Chin,Cem Meydan,Itzel Valencia,Mayumi Sugita,Monica L Guzman,Joshua A Fein,Justin D Kaner,Pinkal Desai,Gail J Roboz,Ari M Melnick,Christopher E Mason,Sanjay S Patel
{"title":"Wild-type p53 overexpression in NPM1-mutated acute myeloid leukemia: potential implications for disease biology and therapy response.","authors":"Paul D Barone,Siarhei Dzedzik,Ashley S Kleinman,Christopher R Chin,Cem Meydan,Itzel Valencia,Mayumi Sugita,Monica L Guzman,Joshua A Fein,Justin D Kaner,Pinkal Desai,Gail J Roboz,Ari M Melnick,Christopher E Mason,Sanjay S Patel","doi":"10.3324/haematol.2025.288054","DOIUrl":"https://doi.org/10.3324/haematol.2025.288054","url":null,"abstract":"Not available.","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":"33 1","pages":""},"PeriodicalIF":10.1,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145032149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic risk classification in acute myeloid leukemia patients treated with hematopoietic cell transplantation and post-transplant cyclophosphamide. 造血细胞移植和移植后环磷酰胺治疗急性髓系白血病患者的遗传风险分类。
IF 10.1 1区 医学
Haematologica Pub Date : 2025-09-04 DOI: 10.3324/haematol.2025.287860
Marta Villalba,Juan Montoro,Aitana Balaguer-Roselló,Pedro Chorão,Pedro Asensi Cantó,Pablo Granados,Inés Gómez-Seguí,Pilar Solves,Esperanza Such,José Cervera,Eva Barrragán,Marta Santiago,José V Gil-Ortí,Brais Lamas,Ana Bataller,Alberto Louro,Javier De la Rubia,Miguel Á Sanz,Jaime Sanz
{"title":"Genetic risk classification in acute myeloid leukemia patients treated with hematopoietic cell transplantation and post-transplant cyclophosphamide.","authors":"Marta Villalba,Juan Montoro,Aitana Balaguer-Roselló,Pedro Chorão,Pedro Asensi Cantó,Pablo Granados,Inés Gómez-Seguí,Pilar Solves,Esperanza Such,José Cervera,Eva Barrragán,Marta Santiago,José V Gil-Ortí,Brais Lamas,Ana Bataller,Alberto Louro,Javier De la Rubia,Miguel Á Sanz,Jaime Sanz","doi":"10.3324/haematol.2025.287860","DOIUrl":"https://doi.org/10.3324/haematol.2025.287860","url":null,"abstract":"We analyzed outcomes of 217 AML patients in complete remission who underwent allogeneic HCT with myeloablative conditioning and post-transplant cyclophosphamide-based GVHD prophylaxis, aiming to assess the prognostic significance of genetic risk categories. In the overall cohort, the 2-year overall survival (OS) and event-free survival (EFS) were 77% (95% CI, 71-83) and 72% (95% CI, 66- 78), respectively. ELN2022 risk stratification lacked prognostic value in HCT. Instead, we identified four risk categories with distinct impact on OS: standard risk (ELN2022 favorable/intermediate and adverse-risk without high-risk genetic under the defined subcategories), intermediate risk (≥2 myelodysplasia-related gene mutations) (HR 2.23, 95% CI 1.14-4.92), adverse risk (complex karyotype, monosomal karyotype, inv(3)/t(3;3), KMT2A rearrangement) (hazard ratio (HR) 4.24, 95% CI 2.00 - 9.02), and very adverse risk (TP53 mutations) (HR 6.81, 95% CI 3.00 - 15.5). These categories demonstrated similar predictive power for EFS and cumulative incidence of relapse. Moreover, integrating pre-transplant MRD refined risk stratification, identified MRDnegative patients with ≥2 myelodysplasia-related gene mutations whose OS and EFS were comparable to standard-risk patients. This refined classification improves the prognostic value of ELN2022 for AML patients undergoing allogeneic HCT with modern platform by integrating genetic features and MRD status to better guide post-transplant management.","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":"27 1","pages":""},"PeriodicalIF":10.1,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144962670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Caffeine impairs red blood cell storage quality by dual inhibition of ADORA2b signaling and G6PD activity. 咖啡因通过双重抑制ADORA2b信号和G6PD活性来损害红细胞储存质量。
IF 7.9 1区 医学
Haematologica Pub Date : 2025-09-04 DOI: 10.3324/haematol.2025.288332
Monika Dzieciatkowska, Ariel Hay, Aaron Issaian, Gregory R Keele, Shaun Bevers, Travis Nemkov, Julie A Reisz, Mark Maslanka, Daniel Stephenson, Amy L Moore, Xutao Deng, Mars Stone, Kirk C Hansen, Steve Kleinman, Philip J Norris, Michael P Busch, Grier P Page, Nareg Roubinian, Yang Xia, James C Zimring, Angelo D'Alessandro
{"title":"Caffeine impairs red blood cell storage quality by dual inhibition of ADORA2b signaling and G6PD activity.","authors":"Monika Dzieciatkowska, Ariel Hay, Aaron Issaian, Gregory R Keele, Shaun Bevers, Travis Nemkov, Julie A Reisz, Mark Maslanka, Daniel Stephenson, Amy L Moore, Xutao Deng, Mars Stone, Kirk C Hansen, Steve Kleinman, Philip J Norris, Michael P Busch, Grier P Page, Nareg Roubinian, Yang Xia, James C Zimring, Angelo D'Alessandro","doi":"10.3324/haematol.2025.288332","DOIUrl":"10.3324/haematol.2025.288332","url":null,"abstract":"<p><p>Caffeine is the most widely consumed psychoactive substance globally, yet its peripheral physiological effects remain incompletely understood. Leveraging comprehensive data from 13,091 blood donors in the REDS RBC-Omics study, we identify caffeine as a significant modulator of red blood cell (RBC) storage quality and transfusion outcomes. Elevated caffeine levels were reproducible across multiple donations from 643 recalled donors, selected based on their extremes in hemolytic propensity. Both in the screening and recalled cohorts, higher caffeine levels were associated with disrupted RBC metabolism, characterized by reduced glycolysis, depletion of adenylate pools or 2,3-bisphosphoglycerate, and increased markers of oxidative stress and osmotic fragility, including kynurenine accumulation. These observations were recapitulated in plasma and RBCs of eight volunteers upon consumption of a cup of coffee independently of brewing method (Chemex vs espresso). Clinically, elevated caffeine correlated with increased hemolysis and lower post-transfusion hemoglobin increments, especially pronounced in recipients transfused with RBCs from donors carrying common polymorphisms in the ADORA2b gene, a key regulator of RBC metabolism in hypoxia. These human findings were mechanistically validated using a murine model deficient in ADORA2b, which demonstrated impaired glycolytic flux, compromised antioxidant defenses - including caffeine-dependent direct inhibition of recombinantly-expressed glucose 6-phosphate dehydrogenase, and decreased transfusion efficacy (lower hemoglobin increments, higher bilirubin posttransfusion), effects further exacerbated by caffeine exposure during storage. Our study positions caffeine consumption as a modifiable factor in blood transfusion practice, advocating for precision strategies that integrate genetic and exposome factors, and identifies metabolic interventions to enhance blood quality and clinical outcomes.</p>","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":" ","pages":""},"PeriodicalIF":7.9,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144992288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The invisible divide: the impact of racial and geographic disparities on multiple myeloma outcomes - insights from a single-site study. 看不见的鸿沟:种族和地理差异对多发性骨髓瘤结果的影响——来自单点研究的见解。
IF 10.1 1区 医学
Haematologica Pub Date : 2025-09-04 DOI: 10.3324/haematol.2025.287760
Michael A Bauer,Phillip Farmer,Joseph L Su,Mario Schootman,Chenghui Li,Frits Van Rhee,Samer Al Hadidi,Carolina Schinke,John D Shaughnessy,Fenghuang Zhan,Cody Ashby
{"title":"The invisible divide: the impact of racial and geographic disparities on multiple myeloma outcomes - insights from a single-site study.","authors":"Michael A Bauer,Phillip Farmer,Joseph L Su,Mario Schootman,Chenghui Li,Frits Van Rhee,Samer Al Hadidi,Carolina Schinke,John D Shaughnessy,Fenghuang Zhan,Cody Ashby","doi":"10.3324/haematol.2025.287760","DOIUrl":"https://doi.org/10.3324/haematol.2025.287760","url":null,"abstract":"Not available.","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":"61 1","pages":""},"PeriodicalIF":10.1,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144962656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信